Executives On The Move: Cellectis, AbbVie and More
Executive Summary
Recent executive changes in the industry include C-suite changes at Abbvie and Ceylad Oncology. Meanwhile, new directors were appointed at Cellectis and Eyepoint Pharmaceuticals, among others.
You may also be interested in...
Pipeline Watch: Six Approvals And 26 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: Changes At The Top At Aileron, KalVista And More
Recent moves in the industry include new chief medical officers at Rigel Pharmaceuticals and FibroGen, while Aileron Therapeutics and KalVista get new CEOs.
Pipeline Watch: Six Approvals And 18 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.